{"schema_version":"secwatch.filing_event.v1","accession":"0001387131-23-007276","form_type":"8-K","ticker":"CRVW","cik":"0001377149","company_name":"CareView Communications Inc","filed_at":"2023-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.638847+00:00","generated_at":"2026-06-14T06:27:07.747595+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CareView amends credit agreement: PIK interest, mandatory prepayments, maturity extended to Dec 2024","bullets":["Accrued interest on Tranche One and Three loans to be paid-in-kind (added to principal) instead of cash.","Mandatory prepayments required if excess cash flow exceeds $600k, cash over $1.2M, or new debt proceeds.","Maturity date extended to December 31, 2024.","Amendment conditioned on exchange of HealthCor Obligations for equity and release of liens."],"urls":{"canonical":"https://secwatch.observer/filing/0001387131-23-007276","json":"https://secwatch.observer/filing/0001387131-23-007276.json","markdown":"https://secwatch.observer/filing/0001387131-23-007276.md","text":"https://secwatch.observer/filing/0001387131-23-007276.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1377149/000138713123007276/0001387131-23-007276-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1377149/000138713123007276/crvw-8k_053123.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T06:27:07.747595+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8ba8c7c9a99116ff3eb3f5cf2d0bc99f2074fde0","claim":"CareView Communications Inc amended credit facility with PDL Investment Holdings, LLC maturing December 31, 2024.","evidence_excerpt":"On May 31, 2023 (the “Effective Date”), the Company, the Borrower, the Lender, Steven G. Johnson, President and Chief Executive Officer of the Company, and Dr. James R. Higgins, a director of the Company, entered into a Seventh Amendment to Credit Agreement (the “Seventh Credit Agreement Amendment”), pursuant to which the parties agreed to amend the Credit Agreement to, among other things, (i) provide that, after the Effective Date, all accrued but unpaid interest (including interest accrued but unpaid prior to the Effective Date and excluding interest payable on the Maturity Date, in connection with any prepayment, or in the event of an Event of Default, which interest will be payable in cash) accruing on Tranche One Loans and Tranche Three Loans will be paid-in-kind on each Interest Payment Date by being added to the aggregate principal balance of the respective loans in arrears on each Interest Payment Date; (ii) require certain mandatory prepayments of the loans by the Company, inc","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1377149/000138713123007276/0001387131-23-007276-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"credit facility"},{"label":"Counterparty","value":"PDL Investment Holdings, LLC"},{"label":"Maturity","value":"December 31, 2024"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"},{"claim_id":"50a7f2a684423d0c69be735ac2821a9ef720aec0","claim":"CareView Communications Inc amended Seventh Amendment to Credit Agreement with PDL Investment Holdings, LLC (as assignee of PDL BioPharma, Inc.), in its capacity as administrative agent and lender (effective 2023-05-31).","evidence_excerpt":"On May 31, 2023 (the “Effective Date”), the Company, the Borrower, the Lender, Steven G. Johnson, President and Chief Executive Officer of the Company, and Dr. James R. Higgins, a director of the Company, entered into a Seventh Amendment to Credit Agreement (the “Seventh Credit Agreement Amendment”),","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1377149/000138713123007276/0001387131-23-007276-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"PDL Investment Holdings, LLC (as assignee of PDL BioPharma, Inc.), in its capacity as administrative agent and lender"},{"label":"Effective","value":"2023-05-31"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}